Trinity Biotech plc (TRIB)
NASDAQ: TRIB · Real-Time Price · USD
0.6675
-0.0166 (-2.43%)
At close: Jun 5, 2026, 4:00 PM EDT
0.6780
+0.0105 (1.57%)
After-hours: Jun 5, 2026, 7:15 PM EDT
Trinity Biotech Revenue
In the year 2025, Trinity Biotech had annual revenue of $43.79M, down -28.87%. Trinity Biotech had revenue of $11.07M in the quarter ending December 31, 2025.
Revenue (ttm)
$43.79M
Revenue Growth
-28.87%
P/S Ratio
0.31
Revenue / Employee
$152,561
Employees
287
Market Cap
13.52M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 43.79M | -17.77M | -28.87% |
| Dec 31, 2024 | 61.56M | 4.72M | 8.31% |
| Dec 31, 2023 | 56.83M | -5.69M | -9.10% |
| Dec 31, 2022 | 62.52M | -18.63M | -22.96% |
| Dec 31, 2021 | 81.15M | -20.83M | -20.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| IRIDEX | 52.58M |
| Lifeward | 20.92M |
| Vivos Therapeutics | 19.57M |
| IceCure Medical | 3.57M |
| VolitionRx | 2.47M |
| Sintx Technologies | 1.03M |
| Co-Diagnostics | 718.17K |
| Nexalin Technology | 275.58K |
TRIB News
- 3 days ago - Trinity Biotech Registration statement: Registration filing - Filings
- 24 days ago - Trinity Biotech files to sell 167.95M American depositary shares - TheFly
- 24 days ago - Trinity Biotech Registration statement: Registration filing - Filings
- 24 days ago - Trinity Biotech Registration statement: Registration filing - Filings
- 5 weeks ago - Trinity Biotech Appoints Jerry Lydon to Lead North America Commercial Operations - GlobeNewsWire
- 5 weeks ago - Trinity Biotech Annual report: Q4 2025 - Filings
- 5 weeks ago - Trinity Biotech Slides: Q4 2025 - Filings
- 2 months ago - Trinity Biotech Announces Successful Clinical Results for Its Enhanced EpiCapture™ Prostate Cancer Test - GlobeNewsWire